References
- LARGENT et al.: Proc. Natl. Acad. Sci. USA (1984) 81:5618.
- WATSON: J. Pharmacol. Exp. Ther. (1986) 237–411.
- VU TH, WEISSMAN AD, LONDON ED: J. Neurochem. (1990)54:598–603.
- WEISSMAN AD, SU TP, HEDREEN JC, LONDON ED: J.Pharmacol. Exp. Ther. (1988) 247:29–33.
- TAM SW, COOK L: Proc. Natl. Acad. Sci USA (1984) 81:5618–5612.
- SNYDER SH, LARGENT BL: J. Neuropsychiatry (1989) 1:7–15.
- TAYLOR DP, DEKLEVA J: Drug Dev. Res. (1987) 11:65–70.
- YEVICH JP, NEW JS, LOBECK WG eta/.: J. Med. Chem. (1992) 35:4516–4525.
- WALKER JM, BOWEN WD, WALKER FO et al.: Pharmacologi-cal Reviews (1990) 42:355–402.
- PUGSLEY TA, SH1H YH, MELTZER L et al.: In: Multiple Sigmaand PCP Receptor Ligands (1992), KAMENKA JM, DOMINO EF (Eds). NPP Books, Ann Arbor, 117–135.
- FERROSAN, EP-259621.
- MERCK, EP-322034.
- FERROSAN, EP-349956,
- RROSAN, EP-384285.